Zacks Industry Outlook Highlights: CIGNA, Aetna, Humana, Health Net and UnitedHealth Group

Zacks

For Immediate Release

Chicago, IL – July 17, 2013 – Today, Zacks Equity Research discusses the U.S. Health Insurance, including CIGNA Corp. (CI-Free Report), Aetna Inc. (AET-Free Report), Humana Inc. (HUM-Free Report), Health Net, Inc. (HNT-Free Report) and UnitedHealth Group Inc. (UNH-Free Report).

Industry: Health Insurance

Link: http://www.zacks.com/commentary/28154/health-insurance-stock-outlook-july-2013

The health insurance industry has confronted many external challenges in the recent past such as federal, state legislative and regulatory reforms; a challenge to meet the demand of more price- and service-conscious consumers, a fiercely competitive market, shift of customer mix and uncertain economic conditions in the U.S. and abroad, just to name a few.

Notwithstanding the headwinds, the industry is "thriving under stress." Most of the top players -- including CIGNA Corp. (CI-Free Report), Aetna Inc. (AET-Free Report), Humana Inc. (HUM-Free Report) and Health Net, Inc. (HNT-Free Report) -- reported ahead of the Zacks Consensus estimates in 2013 Q1, while UnitedHealth Group Inc. (UNH-Free Report) reported in line. The earnings outperformance was driven by lower medical inflationary trends and strong operating performance.

Following the first quarter results, most of the carriers raised their 2013 earnings estimates, reflecting optimism for the rest of the year. We, however, expect narrower margins in 2013 compared to the strong margins in the 2010-2012 period, when favorable prior-period claim development and continued lower-than-expected utilization helped the industry witness strong margins.

Margins are anticipated to decline in 2013 and beyond as medical costs will likely return to more normal levels and pricing may not increase to that extent.

About the Industry

The health and medical insurance industry is an integral part of the U.S. economy. According to the Centers for Medicare and Medicaid Services, U.S. health expenditures account for approximately 18% of the country's GDP. According to the World Health Organization, health care expenditure per person in the U.S. is the highest in the world.

Despite a huge sum of money being spent on health care, millions of Americans lack health insurance coverage or are underinsured. This is largely due to a dysfunctional health care system, in place for decades. To rein in wastage and make health care more accessible, effective and affordable, the current administration came out with a major reform in the shape of the Affordable Care Act, commonly referred to as Obamacare. This massive piece of legislation has elicited mixed responses from the get-go, largely along partisan lines, and is still not fully functional.

Industry Ranking

Within the Zacks Industry classification, Health Insurance is broadly grouped into two sectors: Medical and Finance. The Medical HMO industry is within the Medical sector while the Multi-line Insurance industry is within the Finance sector. The Multi-line insurance industry houses within its category all kinds of operators that have multiple lines of insurance business, including healthcare.

We rank all the industries in the 16 Zacks sectors based on the earnings outlook for the constituent companies in each industry. The ranking is available on the Zacks Industry Rank page. http://www.zacks.com/stocks/industry-rank

As a point of reference, the outlook for industries with Zacks Industry Rank #88 and lower is 'Positive,' between #89 and #176 is 'Neutral' and
#177 and higher is 'Negative.' The current Zacks Industry Rank for the Medical HMO industry is #18, down 8 spots in the last week, while the Multi-line Insurance industry is currently ranked #17, up 10 spots over the past week. With both these industries located towards top of the Zacks Industry Rank list, the outlook for the healthcare insurance space remains positive.

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros.  In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time!  Click here for your free subscription to Profit from the Pros.

Get the full Report on CI - FREE

Get the full Report on AET - FREE

Get the full Report on HUM - FREE

Get the full Report on HNT - FREE

Get the full Report on UNH - FREE

Follow us on Twitter:  http://twitter.com/zacksresearch

Join us on Facebook:  http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact
Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

http://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Read the analyst report on CI

Read the analyst report on AET

Read the analyst report on HUM

Read the analyst report on HNT

Read the analyst report on UNH

Zacks Investment Research



More From Zacks.com

Rates

View Comments (0)